SNOA News and Press, Sonoma Pharmaceuticals Inc. From 06/08/23

BOULDER, CO / ACCESSWIRE / June 8, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, dermatology, a...

BOULDER, CO / ACCESSWIRE / April 11, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) , a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and n...

2023-03-29 10:05:07 ET Gainers: Kodiak Sciences ( KOD ) +19% . Arcturus Therapeutics ( ARCT ) +16% . Erasca ( ERAS ) +15% . G Medical Innovations ( GMVD ) +15% . Atai Life Sciences ( ATAI ) +13% . Losers: ProQR The...

BOULDER, CO / ACCESSWIRE / March 28, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal...

2023-03-10 08:27:32 ET Barnes & Noble Education ( BNED ) +19% on Q3 earnings. Unicycive Therapeutics ( UNCY ) +20% . Stratasys ( SSYS ) +13% on Nano Dimension offers to acquire Stratasys for $18 a share. Heritage Global ( HGBL ) +1...

Praxis Precision Medicines PRAX -49% after mid-stage data for movement disorder candidate . Veru VERU -34% after Veru COVID respiratory treatment sabizabulin declined authorization by FDA . Cidara Therapeutics ( CDTX ) -17% on launching concurrent but separa...

Penny Stocks To Watch Building a penny stocks watch list is easier than you think. You don’t necessarily need to know a company’s financial history or its management’s business acumen. When trading penny stocks , the usual action taken is trading them. Even though the...

BOULDER, CO / ACCESSWIRE / March 2, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasa...

Sonoma Pharmaceuticals press release ( NASDAQ: SNOA ): Q3 GAAP EPS of -$0.62. Revenue of $2.94M (+1.4% Y/Y). For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.62, revenue of $2.94M

Cash burn of $717,000 for the quarter ended December 31, 2022, 68% less than prior quarter cash burn of $2,235,000 Revenues for three and nine months ended December 31, 2022 essentially flat with strong performance in international sales European revenues increased 51% for the quarter a...